Clinical trials

  • colecalciferol for Healthy volunteers
  • selinexor for Diffuse large B-cell lymphoma (DLBCL) | Relapsed/refractory DLBCL
  • BICALUTAMIDE for Unfavorable intermediate-risk prostate cancer | High-risk prostate cancer
  • MK-1084 for Non-small cell lung cancer
  • TEZEPELUMAB for Severe asthma
  • 4-[3-(CYANOMETHYL)-3-(3',5'-DIMETHYL-1H,1'H-[4,4'-BIPYRAZOL]-1-YL)AZETIDIN-1-YL]-2,5-DIFLUORO-N-[(2S)-1,1,1-TRIFLUOROPROPAN-2-YL]BENZAMIDE for Prurigo nodularis
  • Amoxicillin trihydrate for Community-acquired alveolar pneumonia
  • ESCHERICHIA COLI DSM 17252 for Irritable bowel syndrome|Diarrhea-predominant irritable bowel syndrome (IBS-D)
  • 4-[3-(CYANOMETHYL)-3-(3',5'-DIMETHYL-1H,1'H-[4,4'-BIPYRAZOL]-1-YL)AZETIDIN-1-YL]-2,5-DIFLUORO-N-[(2S)-1,1,1-TRIFLUOROPROPAN-2-YL]BENZAMIDE for Prurigo nodularis
  • Extracellular vesicle-enriched secretome of cardiovascular progenitor cells for Non-ischemic dilated cardiomyopathy
  • Valemetostat for Metastatic castration-resistant prostate cancer (mCRPC)
  • Esketamine hydrochloride for Complex regional pain syndrome